Ascendia Chief Business Officer Robert Bloder will participate in the 13th Portfolio Management and Pipeline Optimization for Generics being held on September 30 – October 1. The event, a Marcus Evans conference, will help attendees maximize partnerships and licensing to accelerate time-to-market while mitigating risk during market and supply chain uncertainty.
Bloder will serve as the moderator for an interactive panel discussion, entitled Calculating the Impact of the Coronavirus to the Pharmaceutical Supply Chain in order to Overcome Disruption to API and Diversity Regional Sourcing. Scheduled panelists are Mr. Rajesh Sadanandan, Global Head – Mature Markets – Active Pharmaceutical Ingredients for Dr. Reddy’s Laboratories; Gopal Venkatesan, Vice President, Business Development, Wockhardt USA, LLC; and Tushar Nuwal, Executive – Business Development, Portfolio, Project, & Alliance Management.
Contact Ascendia to learn more about how we can help meet our drug development pipeline needs.